Bristol-Myers Squibb launches new informational site for patients with CML

NEW YORK A large drug company has created a Web site for patients with chronic myeloid leukemia.

Bristol-Myers Squibb Co. has launched MyCMLCare.com for patients and their caregivers. The site contains downloadable information about CML, as well as links to a site about Sprycel (dasatinib), a Bristol drug used to treat CML.

CML affects nearly 22,000 people in the United States, according to the Leukemia and Lymphoma Society.